Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Nefrología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Desconocido
ClinicalTrials.gov
A SU011248 Expanded Access Protocol For Systemic Therapy Of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible For Participation In Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
EXPANDED_ACCESS
Inicio: 1 de jul de 2005
ID: NCT00130897
Completado
ClinicalTrials.gov
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar
OBSERVATIONAL
Inicio: 1 de jul de 2006
ID: NCT00895674
Completado
Fase 3
ClinicalTrials.gov
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00256750
Reclutando
Fase 2
ClinicalTrials.gov
A Multicenter, Single Arm, Open Label Biopsy Study to Evaluate Structural and Functional Changes in Kidneys of Adult Patients With IgA Nephropathy Receiving Iptacopan on Top of Supportive Care
INTERVENTIONAL
Inicio: 21 de feb de 2025
ID: NCT06797518
Completado
Fase 3
ClinicalTrials.gov
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
INTERVENTIONAL
Inicio: 2 de feb de 2017
ID: NCT03036150
Completado
ClinicalTrials.gov
PRINCIPAL: A Prospective Observational Study of Real World Treatment Patterns and Treatment Outcomes in Patients With Advanced or Metastatic Renal Cell Carcinoma Receiving Pazopanib
OBSERVATIONAL
Inicio: 19 de jul de 2012
ID: NCT01649778
Completado
Fase 3
ClinicalTrials.gov
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CORRECTION)
INTERVENTIONAL
Inicio: 1 de dic de 2015
ID: NCT02648347
Terminado
ClinicalTrials.gov
Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function
OBSERVATIONAL
Inicio: 1 de oct de 2007
ID: NCT00568009
Terminado
ClinicalTrials.gov
TREATMENT RESISTANCE FOLLOWING ANTI-CANCER THERAPIES (TRANSLATE)
INTERVENTIONAL
Inicio: 13 de feb de 2019
ID: NCT04436120
Aún no recluta
ClinicalTrials.gov
Development and Validation of an Obstetric Organ Dysfunction Score to Predict Mortality in Intensive Care Unit: A Multicenter, Prospective, Cohort Study
OBSERVATIONAL
Inicio: 1 de ago de 2025
ID: NCT07068022
Completado
ClinicalTrials.gov
Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
OBSERVATIONAL
Inicio: 1 de may de 2011
ID: NCT01467271
Completado
Fase 2
ClinicalTrials.gov
A 12 Month Open-label, Randomized, Multicenter, Sequential Cohort-group, Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of Oral AEB071 Versus Cyclosporine in Combination With Everolimus, Basiliximab and Corticosteroids in de Novo Adult Renal Transplant Recipients.
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00504543
Reclutando
Fase 2
ClinicalTrials.gov
A Phase IIa, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Assess the Efficacy, Safety, and Tolerability of AZD4144 in Participants With Sepsis-associated Acute Kidney Injury (SERENIA)
INTERVENTIONAL
Inicio: 10 de feb de 2026
ID: NCT07215702
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis
INTERVENTIONAL
Inicio: 21 de oct de 2022
ID: NCT05485961
Completado
Fase 3
ClinicalTrials.gov
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE - CORRECTION/CONVERSION)
INTERVENTIONAL
Inicio: 1 de jul de 2016
ID: NCT02865850
Terminado
Fase 2
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Parallel-group Dose-finding Study to Assess the Effect of 3 Doses of LIK066 Compared to Placebo or Empagliflozin in Type 2 Diabetes Mellitus Patients With Heart Failure
INTERVENTIONAL
Inicio: 25 de jul de 2017
ID: NCT03152552
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Phase 3 Study of Nivolumab (BMS-936558) vs. Everolimus in Subjects With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
INTERVENTIONAL
Inicio: 9 de oct de 2012
ID: NCT01668784
Terminado
Fase 3
ClinicalTrials.gov
A PROSPECTIVE, RANDOMIZED,OPEN-LABEL, COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF AZTREONAM- AVIBACTAM (ATM-AVI) AND BEST AVAILABLE THERAPY FOR THE TREATMENT OF SERIOUS INFECTIONS DUE TO MULTI-DRUG RESISTANT GRAM- NEGATIVE BACTERIA PRODUCING METALLO -Β-LACTAMASE (MBL)
INTERVENTIONAL
Inicio: 25 de dic de 2020
ID: NCT03580044
Completado
Fase 4
ClinicalTrials.gov
Planned Transition To Sirolimus-Based Therapy Versus Continued Tacrolimus-Based Therapy In Renal Allograft Recipients
INTERVENTIONAL
Inicio: 1 de jun de 2009
ID: NCT00895583
Completado
Fase 3
ClinicalTrials.gov
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
INTERVENTIONAL
Inicio: 11 de may de 2017
ID: NCT03029208
Anterior
1
...
8
9
10
...
434
Siguiente
Filtros